Literature DB >> 20559700

Targeted polymeric micelle system for delivery of combretastatin A4 to tumor vasculature in vitro.

Yiguang Wang1, Tingyuan Yang, Xun Wang, Jiancheng Wang, Xuan Zhang, Qiang Zhang.   

Abstract

PURPOSE: To develop an efficient tumor vasculature-targeted polymeric micelle delivery system for combretastatin A4 (CA4), a novel antivascular agent.
METHODS: CA4-loaded micelles were prepared from poly (ethylene glycol)-b-poly (d, l-lactide) copolymers. RGD peptides that target integrins alphavbeta3 and alphavbeta5, markers of angiogenic endothelial cells, were coupled to the surface of micelles. The micelles were characterized in terms of particle size, morphology, drug loading, and drug release. Cellular uptake of micelles was evaluated by fluorometric determination and confocal microscopy. Anti-proliferation of targeted micelles was also evaluated by SRB method.
RESULTS: The mean diameters of CA4-loaded targeted micelles were 25.9 +/- 1.3 nm and spherical in shape. Approximately 4 mg/mL of micellar CA4 loading was obtained with an entrapment efficiency of 97.2 +/- 1.4%. In vitro release studies revealed that targeted micelles release CA4 in a sustained-release manner within 48 h. In vitro cellular uptake studies demonstrated that targeted micelles significantly facilitated the intracellular delivery of the encapsulated agents via integrin-mediated endocytosis. Anti-proliferation studies showed that targeted micelles containing CA4 present superior efficacy over nontargeted micelles.
CONCLUSION: These results suggested that RGD conjugated PEG-PLA micelles loading CA4 have potential as a new formulation for targeting angiogenic tumor vasculature.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20559700     DOI: 10.1007/s11095-010-0184-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  29 in total

1.  The effect of block copolymer structure on the internalization of polymeric micelles by human breast cancer cells.

Authors:  Abdullah Mahmud; Afsaneh Lavasanifar
Journal:  Colloids Surf B Biointerfaces       Date:  2005-10-10       Impact factor: 5.268

Review 2.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

Authors:  H Maeda; J Wu; T Sawa; Y Matsumura; K Hori
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

3.  Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells.

Authors:  Xiao-Bing Xiong; Abdullah Mahmud; Hasan Uludağ; Afsaneh Lavasanifar
Journal:  Biomacromolecules       Date:  2007-02-22       Impact factor: 6.988

4.  Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.

Authors:  R E Eliaz; F C Szoka
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

5.  New colorimetric cytotoxicity assay for anticancer-drug screening.

Authors:  P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

Review 6.  Combretastatin A4 phosphate: background and current clinical status.

Authors:  Scott L Young; David J Chaplin
Journal:  Expert Opin Investig Drugs       Date:  2004-09       Impact factor: 6.206

7.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

8.  Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression.

Authors:  L Holmgren; M S O'Reilly; J Folkman
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

9.  RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells.

Authors:  Yiguang Wang; Xun Wang; Yifei Zhang; Shijin Yang; Jiancheng Wang; Xuan Zhang; Qiang Zhang
Journal:  J Drug Target       Date:  2009-07       Impact factor: 5.121

10.  In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug.

Authors:  K Grosios; S E Holwell; A T McGown; G R Pettit; M C Bibby
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

View more
  9 in total

Review 1.  Bibliometric analysis of nanotechnology applied in oncology from 2002 to 2011.

Authors:  Xifeng Dong; Xiao-chun Qiu; Qian Liu; Jack Jia
Journal:  Tumour Biol       Date:  2013-12

2.  Antibody-drug nanoparticle induces synergistic treatment efficacies in HER2 positive breast cancer cells.

Authors:  Muhammad Raisul Abedin; Kaitlyne Powers; Rachel Aiardo; Dibbya Barua; Sutapa Barua
Journal:  Sci Rep       Date:  2021-04-01       Impact factor: 4.379

3.  Curcumin Delivery by Poly(Lactide)-Based Co-Polymeric Micelles: An In Vitro Anticancer Study.

Authors:  Preeti Kumari; Muddineti Omkara Swami; Sravan Kumar Nadipalli; Srividya Myneni; Balaram Ghosh; Swati Biswas
Journal:  Pharm Res       Date:  2015-11-23       Impact factor: 4.200

Review 4.  Recent advances in PEG-PLA block copolymer nanoparticles.

Authors:  Ren Zhong Xiao; Zhao Wu Zeng; Guang Lin Zhou; Jun Jie Wang; Fan Zhu Li; An Ming Wang
Journal:  Int J Nanomedicine       Date:  2010-11-26

5.  Multifunctional dendrimer/combretastatin A4 inclusion complexes enable in vitro targeted cancer therapy.

Authors:  Mengen Zhang; Rui Guo; Yin Wang; Xueyan Cao; Mingwu Shen; Xiangyang Shi
Journal:  Int J Nanomedicine       Date:  2011-10-14

6.  Proinflammatory macrophage-derived microvesicles exhibit tumor tropism dependent on CCL2/CCR2 signaling axis and promote drug delivery via SNARE-mediated membrane fusion.

Authors:  Ling Guo; Ye Zhang; Runxiu Wei; Xiaochen Zhang; Cuifeng Wang; Min Feng
Journal:  Theranostics       Date:  2020-05-17       Impact factor: 11.556

7.  Polymeric micelles loading with ursolic acid enhancing anti-tumor effect on hepatocellular carcinoma.

Authors:  Meiling Zhou; Youping Yi; Li Liu; Yan Lin; Jian Li; Jinghua Ruan; Zhirong Zhong
Journal:  J Cancer       Date:  2019-10-06       Impact factor: 4.207

Review 8.  Combretastatins: An Overview of Structure, Probable Mechanisms of Action and Potential Applications.

Authors:  Gökçe Şeker Karatoprak; Esra Küpeli Akkol; Yasin Genç; Hilal Bardakci; Çiğdem Yücel; Eduardo Sobarzo-Sánchez
Journal:  Molecules       Date:  2020-05-31       Impact factor: 4.411

Review 9.  Peptide-Based Drug-Delivery Systems in Biotechnological Applications: Recent Advances and Perspectives.

Authors:  Diego Tesauro; Antonella Accardo; Carlo Diaferia; Vittoria Milano; Jean Guillon; Luisa Ronga; Filomena Rossi
Journal:  Molecules       Date:  2019-01-19       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.